What You Should Know:
- Today, PhysIQ Inc. announced its partnership with Johns Hopkins University, Duke University and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), to support a clinical trial to evaluate products for early treatment and post-exposure treatment of COVID-19. The 18-month study will assess disease progression and provide early indication of infection. This DOD-funded initiative will assess the role of continuous biosensor
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Phenomix Inks Licensing Deal with Mayo Clinic for Obesity Phenotype Blood Test
What You Should Know:
- Today, Phenomix Sciences announced the company has signed an exclusive technology licensing agreement with Mayo Clinic for a novel blood test that accurately predicts obesity phenotypes.
- The multi-level “omics” MyPhenome™ test leverages technology developed at Mayo Clinic to analyze genomics, metabolomics and hormone levels. Its AI-driven algorithmic solution identifies four specific obesity phenotypes to give doctors the ability to
Read More
CVS Health Launches Employer-Based COVID-19 Vaccination Program
What You Should Know:
Today, CVS Health announced it recently began administering COVID-19 vaccines at employer-based vaccination clinics through Return Ready, the company’s comprehensive COVID-19 solution that helps employers return and maintain healthy workforces.
- With vaccine hesitancy on the rise, federal and state governments are looking to partners, like employers and CVS Health, to help by making vaccines more convenient to access and enhancing public education
Read More
Carevive, COS Ink Partnership to Improve Cancer Care with RWE
What You Should Know:
- Carevive and Clinical Outcome Solutions (COS) announced a new partnership to improve the cancer patient experience using RWE and RWD. The partnership will leverage Carevive’s innovative digital oncology platform to capture the patient experience, and COS’ deep experience in analyzing data, ultimately providing valuable insights for life science companies and regulators alike.
- The Carevive platform PROmpt enables cancer care teams to monitor and manage
Read More
Abbott Launches New AI-Powered Coronary Imaging Platform in Europe
What You Should Know:
- Abbott announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT) – an imaging tool that provides physicians a comprehensive view inside an artery or blood vessel – with the power of artificial intelligence (AI) for enhanced visualization.
- The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure
Read More
Health2047 Spins Out SiteBridge Research Launches to Improve Clinical Trial Access for Small and Community Physician Practices
What You Should Know:
- Health2047, the innovation arm of the American Medical Association, today announced the spinout of a new company, SiteBridge Research, that offers a more accessible way for a broader set of physicians and their patients to participate in clinical research.
- SiteBridge Research creates a network of independent, small practice physicians to gather data from a broader, more inclusive patient population and, ultimately, create more widely applicable clinical
Read More
Streamlining Biospecimen Procurement: Avoid These 8 Common R&D Mistakes
Long before a clinician administers a drug or runs a new test, there is the arduous R&D cycle. Unfortunately, it’s rarely as streamlined as the one that just delivered COVID-19 vaccines in record-shattering time.
For most Americans, vaccines and drugs seem to spring wholly formed from clinical trials, which are becoming part of America’s everyday conversation. But before any vaccine or therapy hits the market, the less-visible pre-clinical research and development must be performed – from
Read More
Syneos, Medable Team Up to Bring Decentralized Clinical Trials to Patients
What You Should Know:
- Syneos Health, a fully integrated biopharmaceutical solutions organization, and Medable, a cloud platform for patient-centered drug development, announced a strategic partnership to bring clinical trials closer to the patient.
- The partnership will deliver new decentralized capabilities to Syneos Health with the aim of increasing clinical trial diversity, while improving patient access and experiences to transform biopharmaceutical product development.
- As part
Read More
Google Cloud Expands Intelligent Vaccine Impact Solution to Support Vaccine Equity
What You Should Know:
- Google Cloud today launched an expanded virtual agent as part of its Intelligent Vaccine Impact solution (IVIs). People will be able to schedule vaccine appointments and ask common questions through a virtual agent, Contact Center AI.
- Contact Center AI (CCAI), one core component of the Intelligent Vaccine Impact solution, scales call center human operations with intelligent virtual agents that understand, interact and can talk with people 24/7 in real-time,
Read More
C2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence Platform
- Cancer intelligence company, C2i Genomics announced it has raised $100M in financing from Casdin Capital, NFX, Duquesne Family Office, Section 32, iGlobe Partners, Driehaus Capital and others.
- Funds will be used to accelerate clinical development and commercialization of the company’s C2-Intelligence Platform, a cancer diagnostics service, that uses AI pattern recognition and whole-genome analysis to provide rapid and cancer-specific detection of residual disease 100x more sensitive than
Read More
